AI assistant
Sending…
PFIZER INC — Director's Dealing 2011
Sep 17, 2011
29831_dirs_2011-09-16_d16e7fe9-e74b-4208-a260-8f602f1766d6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ICAGEN INC (ICGN)
CIK: 0000902622
Period of Report: 2011-09-15
Reporting Person: PFIZER INC (10% Owner)
Reporting Person: Eclipse Acquisition Corp. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-09-15 | Common Stock | P | 232203 | $6 | Acquired | 5326761 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1067015 | Direct |
Footnotes
F1: Shares are directly owned by Eclipse Acquisition Corp., a wholly owned subsidiary of Pfizer Inc.
More from PFIZER INC
Major Shareholding Notification
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 5
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 27
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31